Corcept Therapeutics Inc Net Income per Employee (CORT), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Corcept Therapeutics Inc  (NASDAQ: CORT)
 

Corcept Therapeutics Inc Net Income per Employee

CORT's Quarterly Results, Trends, Rankings, Statistics
Corcept Therapeutics Inc's Income per employee fell in the third quarter 2026 on a trailing twelve month basis to $ 221,411, below the company average number of $80,111.
The Healthcare sector has seen employees of 54 other companies achieving higher income per employee. While Corcept Therapeutics Inc's total ranking has deteriorated compared to the previous quarter from 1192 to 1225.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CORT Net Income per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Net Income Change 554.88 % 21.76 % - -21.36 % -58.54 %
Net Income per Employee (TTM) $ 221,411 74,262 63,947 134,481 143,379
CORT's Total Ranking # 1225 # 1192 # 688 # 323 #
Seq. Net Income Change 200.84 % - - 23.52 % -44.07 %

CORT Company Profile >> Back to CORT Efficiency Comparisons >> Compare CORT Net Income per Employee to its Competitors

CORT Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 55
Healthcare Sector # 104
Overall Market # 1225

Net Income per Employee Statistics
High Average Low
$ 207,852 $ 80,111 $ -65,558
(Sep 30 2018)   (Mar 31 2014)







Companies with similar Income per Employee for 12 month ending Sep 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2026Number of Employees Sep 30 2026
Neurocrine Biosciences Inc   351,250.00 $ 702.500  Million 2,000 
Standard Biotools Inc   342,097.69 $ 133.076  Million 389 
Regeneron Pharmaceuticals Inc   312,615.18 $ 4,817.400  Million 15,410 
Kiniksa Pharmaceuticals International Plc  299,366.12 $ 109.568  Million 366 
Bristol myers Squibb Company  284,338.46 $ 9,241.000  Million 32,500 
Lantheus Holdings Inc   226,240.57 $ 269.905  Million 1,193 
Corcept Therapeutics Inc  221,410.96 $ 161.630  Million 730 
Abbvie Inc   181,508.77 $ 10,346.000  Million 57,000 
Intuitive Surgical Inc   174,578.46 $ 2,971.500  Million 17,021 
Caredx Inc   168,142.48 $ 128.629  Million 765 
Transmedics Group Inc   162,904.23 $ 146.288  Million 898 
Iradimed Corporation  144,481.67 $ 23.984  Million 166 
Incyte Corporation  141,846.34 $ 403.411  Million 2,844 
Resmed Inc   140,120.49 $ 1,593.170  Million 11,370 
Bio rad Laboratories Inc   137,302.01 $ 1,022.900  Million 7,450 
Carlisle Companies Incorporated  121,762.71 $ 718.400  Million 5,900 
Ani Pharmaceuticals Inc  118,691.75 $ 115.131  Million 970 
Johnson and Johnson  114,311.08 $ 16,095.000  Million 140,800 


Date modified: 2026-11-05T14:33:37+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.